Dr. Alexey Streletskiy | Analytical Chemistry | Best Researcher Award

Dr. Alexey Streletskiy | Analytical Chemistry | Best Researcher Award

Centre for Strategic Planning, Russia

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Alexey Streletskiy began his academic journey with a strong foundation in Material Sciences at Moscow State University, Russia. He earned his B.Sc. in 2000 and M.Sc. in 2002, both in Material Sciences, followed by a Ph.D. in Physical Chemistry in 2005. During this time, he was actively involved in research at the Institute of Bioorganic Chemistry, where he explored the synthesis and properties of fullerene derivatives. His academic achievements were complemented by his role as a teaching assistant for the course “Chemical Thermodynamics,” where he guided third-year students, showcasing both his technical knowledge and teaching capabilities.

💼 Professional Endeavors

Dr. Streletskiy has accumulated extensive experience across industry and academia, both in Russia and internationally. Since July 2023, he has served as a Senior Researcher at the Centre for Strategic Planning of the Federal Medical and Biological Agency (CSP, FGBU), focusing on physical chemistry in the field of ecotoxicology. From 2018 to 2023, he was a Senior Analyst at the same center, contributing to strategic research and technical analysis. Between 2009 and 2017, he worked at Rusnano JSC as a Senior R&D Expert, where he played a vital role in scientific evaluation of emerging nanotechnologies, managed technical due diligence, liaised with business partners, and produced analytical reports for investment decision-making. His earlier international tenure included a role as Senior Research Engineer at Cheil Industries, Samsung, in South Korea (2008–2009), where he developed analytical methods for polymers and electronic materials using advanced instruments like MS, NMR, LC-MS, and GC-MS.

🔬 Contributions and Research Focus

Throughout his career, Dr. Streletskiy has consistently bridged fundamental science and applied research. His work spans ecotoxicology, analytical chemistry, nanotechnology, and pharmaceutical analysis. As Leader of the Bioanalytical Group at ASINEX (2006–2008), he led bioanalytical studies of drug compounds using LC/MS/MS and ensured compliance with GLP standards. His early work with fullerene derivatives and their physical-chemical properties reflects his deep interest in molecular chemistry. His current research is vital in supporting environmental and health-related policy through advanced physical chemistry approaches in ecotoxicology.

🌍 Impact and Influence

Dr. Streletskiy’s contributions have had both national and international impact. His scientific expertise helped shape investment strategies and innovation at Rusnano, and his analytical support has been instrumental in guiding public health initiatives at the CSP. His role in developing analytical methodologies at Samsung and his leadership in GLP-compliant bioanalysis at ASINEX highlight his global influence and adaptability across scientific environments.

📚 Academic Citations and Recognition

Dr. Streletskiy has received numerous accolades for his scholarly work. He was awarded Moscow research grants in 2002 and 2004 and received the Luginin’s Award for interlab collaboration in 2004. He earned the prestigious INTAS Fellowship for Young Scientists (2004–2006), affirming his potential in international scientific research. Additionally, he was recognized with the Young Scientist Award at the 2nd Russian Congress of Mass Spectrometry in 2005.

🧪 Technical Skills

Dr. Streletskiy brings a robust portfolio of technical proficiencies in analytical and bioanalytical chemistry. He is experienced with mass spectrometry (MS), nuclear magnetic resonance (NMR), and both gas and liquid chromatography (GC-MS, LC-MS). He has developed and validated methods for polymer and pharmaceutical analysis, conducted due diligence evaluations, and operated within GLP and HSE frameworks. These skills make him an asset in both research and industrial settings.

👨‍🏫 Teaching Experience

In addition to his research roles, Dr. Streletskiy has contributed to scientific education. At Moscow State University, he served as a teaching assistant, helping students grasp core concepts in chemical thermodynamics. He has also trained colleagues and lab personnel on new instrumentation and analytical techniques, reflecting his dedication to knowledge sharing and skill development.

🌟 Legacy and Future Contributions

Dr. Streletskiy’s professional path reflects a unique blend of scientific rigor, practical application, and strategic insight. His work has directly supported advancements in nanotechnology, pharmaceutical research, and environmental health. Looking ahead, his expertise in ecotoxicology positions him to contribute significantly to sustainable scientific policy and environmental safety. His legacy lies in uniting cross-disciplinary scientific excellence with public impact, ensuring his continued relevance in the evolving scientific landscape.

📖Notable Publications

1. Electron capture-induced dissociation of AK dipeptide dications: Influence of ion velocity, crown-ether complexation and collision gas
  • Authors: Bernigaud, V.; Cederquist, H.; Haag, N.; Holm, A.I.S.; Huber, B.A.; Hvelplund, P.; Kadhane, U.; Larsen, M.K.; Manil, B.; Nielsen, S.B.; et al.
  • Journal: International Journal of Mass Spectrometry
  • Year: 2008
2. Growth of p- and n-dopable films from electrochemically generated C₆₀ cations
  • Authors: Bruno, C.; Marcaccio, M.; Paolucci, D.; Castellarin-Cudia, C.; Goldoni, A.; Streletskii, A.V.; Drewello, T.; Barison, S.; Venturini, A.; Zerbetto, F.; et al.
  • Journal: Journal of the American Chemical Society
  • Year: 2008
3. Application and evaluation of solvent-free matrix-assisted laser desorption/ionization mass spectrometry for the analysis of derivatized fullerenes
  • Authors: Kotsiris, S.G.; Vasil’ev, Y.V.; Streletskii, A.V.; Hart, M.; Mark, L.P.; Boltalina, O.V.; Chronakis, N.; Orfanopoulos, M.; Hungerbühler, H.; Drewello, T.
  • Journal: European Journal of Mass Spectrometry
  • Year: 2006
4. Differences in electronic properties of fluorinated and trifluoromethylated fullerenes revealed by their propensity for dianion formation
  • Authors: Streletskiy, A.V.; Hvelplund, P.; Nielsen, S.B.; Liu, B.; Tomita, S.; Goryunkov, A.A.; Boltalina, O.V.
  • Journal: Journal of Chemical Physics
  • Year: 2006
5. Electron transfer reactivity in Matrix-Assisted Laser Desorption/Ionization (MALDI): Ionization energy, electron affinity and performance of the DCTB matrix within the thermochemical framework
  • Authors: Vasil’ev, Y.V.; Khvostenko, O.G.; Streletskii, A.V.; Boltalina, O.V.; Kotsiris, S.G.; Drewello, T.
  • Journal: Journal of Physical Chemistry A
  • Year: 2006

 

Eva Choong | Analytical Chemistry | Women Researcher Award

Dr. Eva Choong | Analytical Chemistry | Women Researcher Award

CHUV – Hôpital Universitaire, Switzerland

👨‍🎓Profiles

🎓 Early Academic Pursuits

Dr. Eva Choong began her academic journey at the University of Lausanne, where she earned her Swiss Federal Diploma in Pharmacy from the Lausanne School of Pharmacy, Department of Sciences (1997–2002). Her interest in the interplay between pharmacology and patient care led her to pursue a PhD in Pharmaceutical Sciences at the University of Geneva (2006–2011), with a thesis on “Clinical and pharmacogenetic studies on response and side effects of psychotropic drugs.” Supervised by Prof. C.B. Eap and co-supervised by Prof. J-L. Veuthey, her doctoral work was honored with highest distinctions, showcasing her early dedication to clinical research and analytical chemistry.

👩‍⚕️ Professional Endeavors

Dr. Choong’s post-doctoral career commenced at the Pharmacogenetics Unit within the Department of Physiology and Pharmacology (2011–2014), where she explored the genetic basis of drug metabolism. From 2015 to mid-2016, she held the role of Senior Scientist (Maître-Assistante) at the University of Geneva’s Pediatric Oncology and Hematology Research Platform, working with Prof. M. Ansari. Since August 2016, she has served as Laboratory Deputy and Scientific Expert in the Laboratory of Clinical Pharmacology at CHUV (Centre Hospitalier Universitaire Vaudois), under the leadership of Prof. L.A. Decosterd, contributing to both operational oversight and high-impact research.

🧪 Contributions and Research Focus

Dr. Choong has made significant contributions to the field of clinical pharmacology, with particular emphasis on therapeutic drug monitoring (TDM), analytical method development, and pharmacogenetics. Her research focuses on optimizing drug therapies for various conditions, notably in infectious diseases and cystic fibrosis, by measuring drug concentrations in biological matrices using LC-MS/MS methods validated to ISO15189:2022 standards. At CHUV, her laboratory is responsible for monitoring over 130 drugs for clinical application and research across Swiss university hospitals.

🌍 Impact and Influence

Dr. Choong’s work has had a lasting impact in bridging the gap between clinical pharmacology and personalized medicine. Her role in developing mass spectrometry-based drug monitoring protocols has influenced treatment paradigms for cystic fibrosis and HIV. She is also a key contributor to collaborative projects such as the Swiss HIV Cohort Study, and has worked with major pharmaceutical entities like Incyte Biosciences to ensure external quality controls in TDM assays. Her expertise is widely recognized within the Swiss medical research community.

📚 Academic Citations and Recognitions

Dr. Choong is the recipient of several prestigious grants and awards, including: Principal Investigator, Cystic Fibrosis Switzerland Foundation Grant (2022, 30,000 CHF); Partner, Swiss National Science Foundation Grant (2022, 643,365 CHF); Lead recipient, Incyte Biosciences grant (2019–2021, 80,000 CHF); Awardee, Lundbeck Institute Prize in Psychiatry (2014); Grantee, NCCR Synapsys (2013); and recipient of two Early Postdoc.Mobility fellowships (2012 & 2013, combined over 65,000 CHF). These accolades attest to her scientific excellence, thought leadership, and the high citation value of her research in peer-reviewed domains.

🛠️ Technical Skills

Dr. Choong is proficient in a range of analytical and clinical methodologies, including: LC-MS and LC-MS/MS in ISO15189-accredited environments; validation of bioanalytical methods for therapeutic monitoring; pharmacokinetics and pharmacogenetics analysis; biostatistics, clinical epidemiology, and regulatory compliance under Swissethics. Her training includes completion of management programs for medical professionals, allowing her to seamlessly integrate leadership and science in hospital and academic settings.

👩‍🏫 Teaching Experience and Mentorship

Throughout her career, Dr. Choong has demonstrated a strong commitment to mentoring junior researchers and medical professionals. Her involvement in training programs, supervision of postgraduates, and contribution to interdisciplinary education at CHUV and the University of Geneva underscores her dedication to the academic and clinical advancement of future professionals in pharmacology and biomedicine.

🌟 Legacy and Future Contributions

With a career rooted in precision medicine, analytical innovation, and translational research, Dr. Choong continues to play a central role in transforming clinical pharmacology in Switzerland. Her ongoing projects aim to expand the utility of mass spectrometry for real-time therapeutic monitoring, develop novel biomarkers, and refine treatment regimens for complex patient populations such as those affected by cystic fibrosis and HIV. As a respected scientific leader, her legacy will be marked by both the technical excellence of her lab and her unwavering commitment to patient-centered innovation.

📖Notable Publications

A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring
Authors: Valentina D’Atri, Fabrizio Corrado, François Versace, Susana Alves Saldanha, Thomas Mercier, Guidi Monia, Paul Thoueille, Sylvain Blanchon, Angela Koutsokera, Michael Vogeser et al.
Journal: Molecules
Year: 2025

Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV
Authors: Thoueille P., Saldanha S.A., Schaller F., Choong E., Veuve F., Munting A., Cavassini M., Braun D., Günthard H.F., Duran Ramirez J.J. et al.
Journal: Clinical Pharmacology & Therapeutics
Year: 2024

Liquid Chromatography Coupled to Tandem Mass Spectrometry (LC-MS/MS) Methods for the Therapeutic Drug Monitoring of Cytotoxic Anticancer Drugs: An Update
Authors: Briki M., Murisier A., Guidi M., Seydoux C., Buclin T., Marzolini C., Girardin F.R., Thoma Y., Carrara S., Choong E. et al.
Journal: Journal of Chromatography B
Year: 2024

Real-World Trough Concentrations and Effectiveness of Long-Acting Cabotegravir and Rilpivirine: A Multicenter Prospective Observational Study in Switzerland
Authors: Thoueille P., Saldanha S.A., Schaller F., Choong E., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B. et al.
Journal: The Lancet Regional Health – Europe
Year: 2024

Development and Validation of a Multiplex HPLC-MS/MS Assay for the Monitoring of JAK Inhibitors in Patient Plasma
Authors: Tachet J., Versace F., Mercier T., Buclin T., Decosterd L.A., Choong E., Girardin F.R.
Journal: Journal of Chromatography B
Year: 2023